Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/40604
Title: Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.
Authors: 
Keywords: 
Mesh: 
Issue Date: Nov-2015
Citation: Eur. Urol..2015 Nov;(68)5:885-90
Abstract: The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in PCa incidence with prostate-specific antigen (PSA)-based screening (at 13 yr of follow-up). We evaluated PCa incidence by risk category at diagnosis across the study arms to assess the potential impact on PCa mortality.
PMID: 25791513
URI: https://hdl.handle.net/20.500.12530/40604
Rights: openAccess
Appears in Collections:Hospitales > H. U. Infanta Cristina > Artículos
Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
PMC4982869.pdf183 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.